Genomadix Names Hollie Huff CEO, Marking a Strategic Step in Company’s Growth Journey
Genomadix Names Hollie Huff CEO, Marking a Strategic Step in Company’s Growth Journey OTTAWA, CANADA, October 29, 2025 – Genomadix (genomadix.com), a global leader in point-of-need precision medicine diagnostics, announced today that Hollie Huff, Ph.D. has been appointed the company’s new Chief Executive Officer. Hollie succeeds Steve Edgett, who will transition into a new strategic […]
Genomadix Names Hollie Huff CEO, Marking a Strategic Step in Company’s Growth Journey Read More »
